Stockholm - Free Realtime Quote SEK
SynAct Pharma AB (SYNACT.ST)
18.90
+0.64
+(3.50%)
As of 10:40:40 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-89,197
-89,197
-100,177
-117,555
-64,997
Investing Cash Flow
0
0
370
27
-6
Financing Cash Flow
87,405
87,405
53,984
200,712
74,323
End Cash Position
61,209
61,209
62,395
108,245
23,997
Issuance of Capital Stock
--
--
59,459
228,945
80,000
Free Cash Flow
-89,197
-89,197
-100,177
-117,555
-64,997
12/31/2021 - 7/11/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XSPRAY.ST Xspray Pharma AB (publ)
33.75
+3.53%
EGTX.ST Egetis Therapeutics AB (publ)
3.5350
-3.15%
ELIC.ST Elicera Therapeutics AB (publ)
4.9150
-1.70%
P0F.F Egetis Therapeutics AB (publ)
0.3065
-8.10%
XINT.ST Xintela AB (publ)
0.4110
-8.67%
ACE.ST Ascelia Pharma AB (publ)
3.9350
+1.29%
DMYD-B.ST Diamyd Medical AB (publ)
9.12
+0.11%
GENO.ST Genovis AB (publ.)
24.15
+0.62%
KAN.ST Kancera AB (publ)
1.0700
+1.71%
LOBE.CN Lobe Sciences Ltd.
0.0250
0.00%